The Efficacy and Safety of Rifaximin vs. Vancomycin in the Treatment of Mild to Moderate C. difficile Infection: A Randomized Double-Blind Active Comparator Trial

Publication/Presentation Date

5-2012

Volume

142

Issue

5

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article

Share

COinS